SURMOUNT-5 showed Mounjaro produces greater average weight loss than Wegovy. But with the new 7.2mg Wegovy dose narrowing the gap, the choice is more nuanced than headline numbers suggest.
Read article →Ozempic contains the same active ingredient as Wegovy but is licensed for type 2 diabetes, not weight loss. Here is what you need to know — and what to use instead.
Read article →NHS access is expanding but still tightly controlled. Here is what the criteria actually say, what the phased rollout means in practice, and what to do if you do not qualify yet.
Read article →Counterfeit GLP-1 medications have been seized in the UK. The MHRA has issued warnings. Here is how to check any pharmacy before you buy — and what the red flags look like.
Read article →The headline monthly price is rarely the full cost. Consultations, needles, delivery, dose escalation and stopping rules all affect what you actually pay. Here is the full picture.
Read article →Eli Lilly raised UK list prices by up to 170% from 1 September 2025 — the highest dose going from £122 to £330. Here is what happened, why, and what it means for private patients.
Read article →The MHRA approved a triple-strength Wegovy dose in January 2026. STEP UP trial data shows 20.7% average weight loss — matching Mounjaro 15mg. Here is who it is for and how to access it.
Read article →